The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.
Identifieur interne : 000836 ( PubMed/Checkpoint ); précédent : 000835; suivant : 000837The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.
Auteurs : R J Biggar [États-Unis] ; J E Neequaye ; A R Neequaye ; G A Ankra-Badu ; P H Levine ; A. Manns ; M. Taylor ; J. Drummond ; D. WatersSource :
- AIDS research and human retroviruses [ 0889-2229 ] ; 1993.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Anticorps anti-HTLVI (sang), Enfant, Enfant d'âge préscolaire, Femelle, Ghana (épidémiologie), Grossesse, Humains, Infections à HTLV-I (), Infections à HTLV-I (immunologie), Infections à HTLV-I (épidémiologie), Lymphomes (), Mâle, Nourrisson, Nouveau-né, Population rurale, Population urbaine, Prostitution, Surveillance de la population, Test ELISA, Études transversales.
- MESH :
- immunologie : Infections à HTLV-I.
- sang : Anticorps anti-HTLVI.
- épidémiologie : Ghana, Infections à HTLV-I.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Femelle, Grossesse, Humains, Infections à HTLV-I, Lymphomes, Mâle, Nourrisson, Nouveau-né, Population rurale, Population urbaine, Prostitution, Surveillance de la population, Test ELISA, Études transversales.
English descriptors
- KwdEn :
- Adolescent, Adult, Child, Child, Preschool, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Ghana (epidemiology), HTLV-I Antibodies (blood), HTLV-I Infections (complications), HTLV-I Infections (epidemiology), HTLV-I Infections (immunology), Humans, Infant, Infant, Newborn, Lymphoma (complications), Male, Middle Aged, Population Surveillance, Pregnancy, Rural Population, Sex Work, Urban Population.
- MESH :
- chemical , blood : HTLV-I Antibodies.
- complications : HTLV-I Infections, Lymphoma.
- epidemiology : Ghana, HTLV-I Infections.
- immunology : HTLV-I Infections.
- Adolescent, Adult, Child, Child, Preschool, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Population Surveillance, Pregnancy, Rural Population, Sex Work, Urban Population.
Abstract
We conducted a population-based serosurvey of urban areas and rural regions of southern Ghana, West Africa. Subjects (3763) of all ages were enrolled from 25 city and village sites and in studies of groups of special interest. "Positive" results were difficult to define because of a high frequency of results that were indeterminate on immunoblotting, the current standard for confirmation of HTLV-I. However, polymerase chain reaction results and HTLV type-specific discriminatory tests proved HTLV-I was present in Ghana. No HTLV-2 positivity was observed. By using strict criteria that considered indeterminate results as negative, the overall prevalence was found to be between 1 and 2% in all areas, with no difference by geographic location. Prevalence rose with age and was higher in adult women than men. However, in substudies of selected populations, we found HTLV prevalence among 124 persons with lymphomas and hematological malignancies was not different from that in the general population. Furthermore, the prevalence in prostitutes was similar to that in the general population and in pregnant women. HTLV-I is present in West Africa, but we were unable to associate HTLV-I seropositivity with malignancy or with prostitution.
DOI: 10.1089/aid.1993.9.505
PubMed: 8347395
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:8347395Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.</title><author><name sortKey="Biggar, R J" sort="Biggar, R J" uniqKey="Biggar R" first="R J" last="Biggar">R J Biggar</name><affiliation wicri:level="2"><nlm:affiliation>National Cancer Institute, Bethesda, Maryland 20852.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>National Cancer Institute, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Neequaye, J E" sort="Neequaye, J E" uniqKey="Neequaye J" first="J E" last="Neequaye">J E Neequaye</name></author><author><name sortKey="Neequaye, A R" sort="Neequaye, A R" uniqKey="Neequaye A" first="A R" last="Neequaye">A R Neequaye</name></author><author><name sortKey="Ankra Badu, G A" sort="Ankra Badu, G A" uniqKey="Ankra Badu G" first="G A" last="Ankra-Badu">G A Ankra-Badu</name></author><author><name sortKey="Levine, P H" sort="Levine, P H" uniqKey="Levine P" first="P H" last="Levine">P H Levine</name></author><author><name sortKey="Manns, A" sort="Manns, A" uniqKey="Manns A" first="A" last="Manns">A. Manns</name></author><author><name sortKey="Taylor, M" sort="Taylor, M" uniqKey="Taylor M" first="M" last="Taylor">M. Taylor</name></author><author><name sortKey="Drummond, J" sort="Drummond, J" uniqKey="Drummond J" first="J" last="Drummond">J. Drummond</name></author><author><name sortKey="Waters, D" sort="Waters, D" uniqKey="Waters D" first="D" last="Waters">D. Waters</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1993">1993</date><idno type="RBID">pubmed:8347395</idno><idno type="pmid">8347395</idno><idno type="doi">10.1089/aid.1993.9.505</idno><idno type="wicri:Area/PubMed/Corpus">000737</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000737</idno><idno type="wicri:Area/PubMed/Curation">000737</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000737</idno><idno type="wicri:Area/PubMed/Checkpoint">000737</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000737</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.</title><author><name sortKey="Biggar, R J" sort="Biggar, R J" uniqKey="Biggar R" first="R J" last="Biggar">R J Biggar</name><affiliation wicri:level="2"><nlm:affiliation>National Cancer Institute, Bethesda, Maryland 20852.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>National Cancer Institute, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Neequaye, J E" sort="Neequaye, J E" uniqKey="Neequaye J" first="J E" last="Neequaye">J E Neequaye</name></author><author><name sortKey="Neequaye, A R" sort="Neequaye, A R" uniqKey="Neequaye A" first="A R" last="Neequaye">A R Neequaye</name></author><author><name sortKey="Ankra Badu, G A" sort="Ankra Badu, G A" uniqKey="Ankra Badu G" first="G A" last="Ankra-Badu">G A Ankra-Badu</name></author><author><name sortKey="Levine, P H" sort="Levine, P H" uniqKey="Levine P" first="P H" last="Levine">P H Levine</name></author><author><name sortKey="Manns, A" sort="Manns, A" uniqKey="Manns A" first="A" last="Manns">A. Manns</name></author><author><name sortKey="Taylor, M" sort="Taylor, M" uniqKey="Taylor M" first="M" last="Taylor">M. Taylor</name></author><author><name sortKey="Drummond, J" sort="Drummond, J" uniqKey="Drummond J" first="J" last="Drummond">J. Drummond</name></author><author><name sortKey="Waters, D" sort="Waters, D" uniqKey="Waters D" first="D" last="Waters">D. Waters</name></author></analytic><series><title level="j">AIDS research and human retroviruses</title><idno type="ISSN">0889-2229</idno><imprint><date when="1993" type="published">1993</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Cross-Sectional Studies</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Female</term><term>Ghana (epidemiology)</term><term>HTLV-I Antibodies (blood)</term><term>HTLV-I Infections (complications)</term><term>HTLV-I Infections (epidemiology)</term><term>HTLV-I Infections (immunology)</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Lymphoma (complications)</term><term>Male</term><term>Middle Aged</term><term>Population Surveillance</term><term>Pregnancy</term><term>Rural Population</term><term>Sex Work</term><term>Urban Population</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps anti-HTLVI (sang)</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Ghana (épidémiologie)</term><term>Grossesse</term><term>Humains</term><term>Infections à HTLV-I ()</term><term>Infections à HTLV-I (immunologie)</term><term>Infections à HTLV-I (épidémiologie)</term><term>Lymphomes ()</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Population rurale</term><term>Population urbaine</term><term>Prostitution</term><term>Surveillance de la population</term><term>Test ELISA</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>HTLV-I Antibodies</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HTLV-I Infections</term><term>Lymphoma</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Ghana</term><term>HTLV-I Infections</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à HTLV-I</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HTLV-I Infections</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps anti-HTLVI</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Infections à HTLV-I</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Cross-Sectional Studies</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Female</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Middle Aged</term><term>Population Surveillance</term><term>Pregnancy</term><term>Rural Population</term><term>Sex Work</term><term>Urban Population</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Infections à HTLV-I</term><term>Lymphomes</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Population rurale</term><term>Population urbaine</term><term>Prostitution</term><term>Surveillance de la population</term><term>Test ELISA</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We conducted a population-based serosurvey of urban areas and rural regions of southern Ghana, West Africa. Subjects (3763) of all ages were enrolled from 25 city and village sites and in studies of groups of special interest. "Positive" results were difficult to define because of a high frequency of results that were indeterminate on immunoblotting, the current standard for confirmation of HTLV-I. However, polymerase chain reaction results and HTLV type-specific discriminatory tests proved HTLV-I was present in Ghana. No HTLV-2 positivity was observed. By using strict criteria that considered indeterminate results as negative, the overall prevalence was found to be between 1 and 2% in all areas, with no difference by geographic location. Prevalence rose with age and was higher in adult women than men. However, in substudies of selected populations, we found HTLV prevalence among 124 persons with lymphomas and hematological malignancies was not different from that in the general population. Furthermore, the prevalence in prostitutes was similar to that in the general population and in pregnant women. HTLV-I is present in West Africa, but we were unable to associate HTLV-I seropositivity with malignancy or with prostitution.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8347395</PMID><DateCreated><Year>1993</Year><Month>09</Month><Day>10</Day></DateCreated><DateCompleted><Year>1993</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0889-2229</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>1993</Year><Month>Jun</Month></PubDate></JournalIssue><Title>AIDS research and human retroviruses</Title><ISOAbbreviation>AIDS Res. Hum. Retroviruses</ISOAbbreviation></Journal><ArticleTitle>The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.</ArticleTitle><Pagination><MedlinePgn>505-11</MedlinePgn></Pagination><Abstract><AbstractText>We conducted a population-based serosurvey of urban areas and rural regions of southern Ghana, West Africa. Subjects (3763) of all ages were enrolled from 25 city and village sites and in studies of groups of special interest. "Positive" results were difficult to define because of a high frequency of results that were indeterminate on immunoblotting, the current standard for confirmation of HTLV-I. However, polymerase chain reaction results and HTLV type-specific discriminatory tests proved HTLV-I was present in Ghana. No HTLV-2 positivity was observed. By using strict criteria that considered indeterminate results as negative, the overall prevalence was found to be between 1 and 2% in all areas, with no difference by geographic location. Prevalence rose with age and was higher in adult women than men. However, in substudies of selected populations, we found HTLV prevalence among 124 persons with lymphomas and hematological malignancies was not different from that in the general population. Furthermore, the prevalence in prostitutes was similar to that in the general population and in pregnant women. HTLV-I is present in West Africa, but we were unable to associate HTLV-I seropositivity with malignancy or with prostitution.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biggar</LastName><ForeName>R J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>National Cancer Institute, Bethesda, Maryland 20852.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neequaye</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Neequaye</LastName><ForeName>A R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Ankra-Badu</LastName><ForeName>G A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>P H</ForeName><Initials>PH</Initials></Author><Author ValidYN="Y"><LastName>Manns</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Drummond</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Waters</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AIDS Res Hum Retroviruses</MedlineTA><NlmUniqueID>8709376</NlmUniqueID><ISSNLinking>0889-2229</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015481">HTLV-I Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>J</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015481" MajorTopicYN="N">HTLV-I Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015490" MajorTopicYN="N">HTLV-I Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008223" MajorTopicYN="N">Lymphoma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011477" MajorTopicYN="N">Sex Work</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014505" MajorTopicYN="N">Urban Population</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="PIP">093027</OtherID><OtherID Source="POP">00229606</OtherID><KeywordList Owner="PIP"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">Africa South Of The Sahara</Keyword><Keyword MajorTopicYN="Y">Antibodies--analysis</Keyword><Keyword MajorTopicYN="N">Biology</Keyword><Keyword MajorTopicYN="N">Demographic Factors</Keyword><Keyword MajorTopicYN="N">Developing Countries</Keyword><Keyword MajorTopicYN="N">Diseases</Keyword><Keyword MajorTopicYN="N">English Speaking Africa</Keyword><Keyword MajorTopicYN="Y">Epidemiologic Methods</Keyword><Keyword MajorTopicYN="N">Examinations And Diagnoses</Keyword><Keyword MajorTopicYN="N">Ghana</Keyword><Keyword MajorTopicYN="N">Immunity</Keyword><Keyword MajorTopicYN="N">Immunologic Factors</Keyword><Keyword MajorTopicYN="Y">Laboratory Examinations And Diagnoses</Keyword><Keyword MajorTopicYN="N">Measurement</Keyword><Keyword MajorTopicYN="N">Physiology</Keyword><Keyword MajorTopicYN="N">Population</Keyword><Keyword MajorTopicYN="N">Population Characteristics</Keyword><Keyword MajorTopicYN="Y">Prevalence</Keyword><Keyword MajorTopicYN="N">Research Methodology</Keyword><Keyword MajorTopicYN="Y">Rural Population</Keyword><Keyword MajorTopicYN="Y">Urban Population</Keyword><Keyword MajorTopicYN="Y">Viral Diseases</Keyword><Keyword MajorTopicYN="N">Western Africa</Keyword></KeywordList><GeneralNote Owner="PIP">TJ: AIDS RESEARCH AND HUMAN RETROVIRUSES.</GeneralNote></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8347395</ArticleId><ArticleId IdType="doi">10.1089/aid.1993.9.505</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><noCountry><name sortKey="Ankra Badu, G A" sort="Ankra Badu, G A" uniqKey="Ankra Badu G" first="G A" last="Ankra-Badu">G A Ankra-Badu</name><name sortKey="Drummond, J" sort="Drummond, J" uniqKey="Drummond J" first="J" last="Drummond">J. Drummond</name><name sortKey="Levine, P H" sort="Levine, P H" uniqKey="Levine P" first="P H" last="Levine">P H Levine</name><name sortKey="Manns, A" sort="Manns, A" uniqKey="Manns A" first="A" last="Manns">A. Manns</name><name sortKey="Neequaye, A R" sort="Neequaye, A R" uniqKey="Neequaye A" first="A R" last="Neequaye">A R Neequaye</name><name sortKey="Neequaye, J E" sort="Neequaye, J E" uniqKey="Neequaye J" first="J E" last="Neequaye">J E Neequaye</name><name sortKey="Taylor, M" sort="Taylor, M" uniqKey="Taylor M" first="M" last="Taylor">M. Taylor</name><name sortKey="Waters, D" sort="Waters, D" uniqKey="Waters D" first="D" last="Waters">D. Waters</name></noCountry><country name="États-Unis"><region name="Maryland"><name sortKey="Biggar, R J" sort="Biggar, R J" uniqKey="Biggar R" first="R J" last="Biggar">R J Biggar</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000836 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000836 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:8347395
|texte= The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:8347395" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |